Jennifer Tseng, MD
James B. Utley Professor
Boston University School of Medicine
Dept of Surgery

MD, University of California, San Francisco
MPH, Harvard School of Public Health



Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon, whose practice encompasses the upper gastrointestinal tract. She has led a group of diverse BIDMC faculty in oncology research, education and care for GI, endocrine, breast, as well as melanomas and sarcomas, and other malignancies.

Dr. Tseng has published more than 100 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care, an important BMC and BUSM mission. She has collaborated with the Massachusetts Department of Public Health to assess the impact of factors including insurance, disparities and health care reform on cancer diagnosis, treatment and prevention. She was the Founding Director of SOAR (Surgical Outcomes Analysis & Research) at UMass in 2007, a research initiative to improve treatment strategies for a broad range of surgical conditions and to develop tools to assess and reduce risk. At BIDMC, she and her co-leaders have led the continued development of SOAR as a health services and outcomes research group.

Dr. Tseng is also a dedicated educator of medical students and residents who has mentored numerous trainees throughout her research career.

Chair
Boston University School of Medicine
Surgery


Chief
Boston Medical Center
Surgery







Yr Title Project-Sub Proj Pubs
2001 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 5F32CA086420-02 3
2000 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 1F32CA086420-01 3
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2017 Nov 02. PMID: 29098284.
  2. Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Br J Cancer. 2017 Oct 05. PMID: 28982112.
  3. Struyvenberg MR, Fong ZV, Martin CR, Tseng JF, Clancy TE, Fernández-Del Castillo C, Tillman HJ, Bellin MD, Freedman SD. Impact of Treatments on Diabetic Control and Gastrointestinal Symptoms After Total Pancreatectomy. Pancreas. 2017 Oct; 46(9):1188-1195. PMID: 28902790.
  4. Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, Fisher RA, Tseng JF. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017 Oct; 266(4):625-631. PMID: 28692469; DOI: 10.1097/SLA.0000000000002385;.
  5. de Geus SWL, Eskander MF, Kasumova GG, Ng SC, Kent TS, Mancias JD, Callery MP, Mahadevan A, Tseng JF. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Cancer. 2017 Nov 01; 123(21):4158-4167. PMID: 28708929; DOI: 10.1002/cncr.30856;.
  6. Tabatabaie O, Kasumova GG, Kent TS, Eskander MF, Fadayomi AB, Ng SC, Critchlow JF, Tawa NE, Tseng JF. Upper extremity deep venous thrombosis after port insertion: What are the risk factors? Surgery. 2017 Aug; 162(2):437-444. PMID: 28535970; DOI: 10.1016/j.surg.2017.02.020;.
  7. Kasumova GG, Eskander MF, de Geus SWL, Neto MM, Tabatabaie O, Ng SC, Miksad RA, Mahadevan A, Rodrigue JR, Tseng JF. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. Surgery. 2017 Aug; 162(2):275-284. PMID: 28487044; DOI: 10.1016/j.surg.2017.03.009;.
  8. Mizrahi M, Tseng JF, Wong D, Tung N, Eskander MF, Berzin TM, Pleskow DK, Sawhney MS. Chronic Pancreatitis-Like Change in BRCA2 Mutation Carriers. Pancreas. 2017 May/Jun; 46(5):679-683. PMID: 28375947; DOI: 10.1097/MPA.0000000000000814;.
  9. Tabatabaie O, Kasumova GG, Eskander MF, Critchlow JF, Tawa NE, Tseng JF. Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies. Am J Clin Oncol. 2017 Feb; 40(1):94-105. PMID: 28106685; DOI: 10.1097/COC.0000000000000361;.
  10. Kasumova GG, Tabatabaie O, Eskander MF, Tadikonda A, Ng SC, Tseng JF. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors. J Am Coll Surg. 2017 Jun; 224(6):1057-1064. PMID: 27965134; DOI: 10.1016/j.jamcollsurg.2016.11.014;.
Showing 10 of 131 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 131 publications over 20 distinct years, with a maximum of 22 publications in 2010

YearPublications
19951
19962
19972
19992
20001
20022
20042
20053
20063
20076
20086
200919
201022
20119
20127
20138
20144
20157
201616
20179
Contact for Mentoring:


830 Harrison Avenue (Moakley), Suite 3400
Boston MA 02118
Google Map


Tseng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department